Compared to other regions of the world, sub-Saharan Africa has made limited progress in the implementation and performance of nationwide human papillomavirus (HPV) …
AS Runge, ME Bernstein, AN Lucas… - Gynecologic oncology …, 2019 - Elsevier
Cervical cancer is the most common cancer in Tanzania. After excluding human immunodeficiency virus, lower respiratory infections, malaria, diarrheal diseases, and …
D Guillaume, DN Waheed, M Schleiff, KK Muralidharan… - Plos one, 2024 - journals.plos.org
Achieving WHO cervical cancer elimination goals will necessitate efforts to increase HPV vaccine access and coverage in low-and-middle-income countries (LMICs). Although LMICs …
A Baidya, V Willens, C Wonodi… - Annual Review of Public …, 2024 - annualreviews.org
Immunization has saved an estimated 154 million lives over the past 50 years since the launch of the Essential (formerly Expanded) Program on Immunization in 1974, representing …
Background The contribution of vaccination to global public health and community wellbeing has been described as one of the greatest success stories of modern medicine. However …
C Morgan, MR Giattas, T Holroyd, A Pfitzer, D Engel… - Vaccine, 2022 - Elsevier
Integration of vaccination against human papillomavirus (HPV) with other essential health services for adolescents has been proposed in global strategies and tested in demonstration …
D Guillaume, DN Waheed, M Schlieff… - Human Vaccines & …, 2022 - Taylor & Francis
Low-and-middle-income countries (LMICs) experience a high burden of cervical cancer. The human papillomavirus (HPV) vaccine prevents high-risk strains of HPV that cause cervical …
D Guillaume, JG Rosen, LB Mlunde… - PLOS Global Public …, 2023 - journals.plos.org
Tanzania has one of the highest cervical cancer incidence and mortality rates in sub- Saharan Africa. The Tanzanian Ministry of Health developed an integrated adolescent …
A Hsiao, V Struckmann, V Stephani, D Mmbando… - Vaccine, 2023 - Elsevier
Objective As part of the Dose Reduction Immunobridging and Safety Study of Two HPV Vaccines in Tanzanian Girls (DoRIS; NCT02834637), the current study is one of the first to …